Lonza opens formulation development and testing lab

By Gareth Macdonald

- Last updated on GMT

Lonza's new formulation and testing lab (Lonza)
Lonza's new formulation and testing lab (Lonza)
Lonza has opened a drug quality testing and formulation laboratory in Basel, Switzerland.

The facility at the Stücki Science Park in Basel will initially on formulation development, drug product analytical development and quality control.

The site will also provide particle testing or container closure integrity testing services.

The contract manufacturing organisation (CMO) said that all services offered at the new laboratory will be available standalone or as part of larger services product development programmes.

A Lonza spokeswoman told us "We chose Basel for Lonza’s first-ever drug product development facility because it offers us access to the world-leading experts in a central location, one that’s a hub of innovation in the pharma industry."

Novartis, Roche, Basilea Pharmaceutica and Actelion are all headquartered in the city.

The spokeswoman also explained that "the lab will support development of large molecules and small molecules that require a parenteral dosage form​."

"We have invested significant capital and operational expenses in order to staff, provide equipment and infrastructure to serve our customers with latest innovation, for competitive reasons we will however not be able to disclose the amount.​"

She added that the firm will not be relocating any of its current testing facilities, explaining that: "Operations at other facilities will not be affected by the opening of the new laboratory​."

Lonza employs 25 people at the laboratory.

2016 guidance

Last month, Lonza raised its full year guidance after growth of its biopharma businesses in the third quarter.

The Swiss life sciences revised its forecast this week​, predicting that operating profit, EBIT, for 2016 will be 15% higher than the CHF524m ($527m) it generated last year​.

Related news

Show more

Related products

show more

eBook: mRNA prospects and scale-up solutions

eBook: mRNA prospects and scale-up solutions

Thermo Fisher Scientific - Biosciences | 22-Mar-2023 | Insight Guide

This mRNA eBook was created by Thermo Fisher Scientific, in collaboration with Genetic Engineering & Biotechnology News (GEN), to provide you with...

Create Better Biologic Treatments with Catalent

Create Better Biologic Treatments with Catalent

Catalent | 21-Feb-2023 | Product Brochure

Deliver safe and stable products to your patients with the help of Catalent Biologics' Limoges, France site, a European Center of Excellence for early-phase...

Trends in Biopharmaceutical Raw Material Selection

Trends in Biopharmaceutical Raw Material Selection

Actylis – The Partner of Choice | 31-Jan-2023 | Business Advice

Join us as our in-house experts, along with Cecile Bellamy from Pfizer, discuss current and future trends in biopharmaceutical raw material selection.

Related suppliers

Follow us


View more